ttIL12
1 abstract
Abstract
A first-in-human phase 1 trial of T cell membrane-anchored tumor targeted IL12 (ATTIL12) -T cell therapy in advanced/metastatic soft tissue and bone sarcoma.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,